Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporine -: Protective effects of vitamins E and C

被引:99
作者
Durak, I
Karabacak, HI
Büyükkoçak, S
Çimen, MYB
Kaçmaz, M
Ömeroglu, E
Öztürk, HS
机构
[1] Ankara Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey
[2] Selcuk Univ, Fac Med, Dept Pathol, Konya, Turkey
[3] Selcuk Univ, Fac Med, Dept Pharmacol, Konya, Turkey
关键词
cyclosporine; nephrotoxicity; free radicals; antioxidants; antioxidant potential;
D O I
10.1159/000044912
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Enzymatic antioxidant defense system and antioxidant defense potential (AOP) were studied in kidney tissue from rabbits treated with cyclosporine (CsA, 25 mg/kg/day), antioxidant vitamins (E, 100 mg/kg/day plus C, 200 mg/kg/day), and CsA plus antioxidant vitamins, and in kidney tissue from control animals. Although no change was observed in superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) and catalase (CAT) activities were found decreased in kidney tissue exposed to CsA for 10 days compared with control tissue. The level of thiobarbituric acid-reagent substances (TBARS) was higher and antioxidant defense potential (AOP) lower in the CsA-treated group compared with the other groups. Histopathological examination reveals important subcellular damage in the renal tissue from the animals treated with CsA. Antioxidant vitamin therapy caused full improvement in the enzyme activities, TBARS levels and AOP, but the subcellular damage was partly ameliorated in the CsA plus vitamin group. Results suggest that CsA impairs the antioxidant defense system and reduces the antioxidant defense potential in the renal tissue. Antioxidant vitamin treatment protects the tissue in part against toxic effects of the drug.
引用
收藏
页码:207 / 211
页数:5
相关论文
共 27 条
[1]   Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat [J].
Abassi, ZA ;
Pieruzzi, F ;
Nakhoul, F ;
Keiser, HR .
HYPERTENSION, 1996, 27 (05) :1140-1148
[2]  
Aebi HI, 1983, METHOD ENZYMAT AN, P673, DOI [DOI 10.1016/B978-0-12-091302-2.50032-3, 10.1016/B978-0-12-091302-2.50032-3]
[3]  
Bagnis C, 1996, NEPHROL DIAL TRANSPL, V11, P507
[4]   INCREASED URINARY-EXCRETION OF THROMBOXANE B-2 AND 2,3-DINOR-TX B-2 IN CYCLOSPORIN-A NEPHROTOXICITY [J].
BENIGNI, A ;
CHIABRANDO, C ;
PICCINELLI, A ;
PERICO, N ;
GAVINELLI, M ;
FURCI, L ;
PATINO, O ;
ABBATE, M ;
BERTANI, T ;
REMUZZI, G .
KIDNEY INTERNATIONAL, 1988, 34 (02) :164-174
[5]   RENAL-FUNCTION AND BLOOD-PRESSURE IN PATIENTS RECEIVING LONG-TERM, LOW-DOSE CYCLOSPORINE THERAPY FOR IDIOPATHIC AUTOIMMUNE UVEITIS [J].
DERAY, G ;
BENHMIDA, M ;
LEHOANG, P ;
MAKSUD, P ;
AUPETIT, B ;
BAUMELOU, A ;
JACOBS, C .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (07) :578-583
[6]  
Durak I, 1996, J CLIN LAB ANAL, V10, P17, DOI 10.1002/(SICI)1098-2825(1996)10:1<17::AID-JCLA4>3.3.CO
[7]  
2-6
[8]   EFFECT OF CYCLOSPORINE ON RAT-LIVER AND KIDNEY GLUTATHIONE CONTENT [J].
DURUIBE, VA ;
OKONMAH, A ;
BLYDEN, GT .
PHARMACOLOGY, 1989, 39 (04) :205-212
[9]   NITRIC-OXIDE IN CARDIOVASCULAR DISORDERS [J].
DUSTING, GJ .
JOURNAL OF VASCULAR RESEARCH, 1995, 32 (03) :143-161
[10]   CYCLOSPORINE-INDUCED ACUTE RENAL DYSFUNCTION IN THE RAT - EVIDENCE OF ARTERIOLAR VASOCONSTRICTION WITH PRESERVATION OF TUBULAR FUNCTION [J].
ENGLISH, J ;
EVAN, A ;
HOUGHTON, DC ;
BENNETT, WM .
TRANSPLANTATION, 1987, 44 (01) :135-141